Literature DB >> 686874

Incidence of gastric side effects in controlled trials with unbranded aspirin and with various long-acting aspirin preparations.

J M Gumpel.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 686874      PMCID： PMC1000254          DOI： 10.1136/ard.37.4.389-a

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  6 in total

1.  Naproxen. A new non-hormonal anti-inflammatory agent. Studies in rheumatoid arthritis.

Authors:  H F Hill; A G Hill; A G Mowat; B M Ansell; J A Mathews; M H Seifert; J M Gumpel; G A Christie
Journal:  Ann Rheum Dis       Date:  1974-01       Impact factor: 19.103

2.  Double-blind comparison of aspirin and 4-(acetamido) phenyl-2-acetoxy-benzoate (benorylate) in rheumatoid arthritis.

Authors:  P N Sperryn; E B Hamilton; V Parsons
Journal:  Ann Rheum Dis       Date:  1973-03       Impact factor: 19.103

3.  Enteric-coated microspherules. A clinical appraisal of two forms of aspirin.

Authors:  W M Fosdick; W L Shepard
Journal:  J Clin Pharmacol J New Drugs       Date:  1969 Mar-Apr

4.  A double-blind cross-over trail of Prenazone and aspirin in the management of rheumatoid arthritis.

Authors:  R Billings; H C Burry; R Grahame; D J Berry; B Donovan
Journal:  Rheumatol Rehabil       Date:  1975-05

5.  A trial of micro-encapsulated and enteric-coated aspirin in rheumatoid arthritis.

Authors:  J E Dippy; M H Pritchard; K N Lloyd
Journal:  Rheumatol Rehabil       Date:  1976-05

6.  Sulindac. Trials of a new anti-inflammatory drug.

Authors:  E C Huskisson; J Scott
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103
  6 in total
  1 in total

1.  Anti-inflammatory/anti-pyretic salicylic acid esters with low gastric ulcerogenic activity.

Authors:  K D Rainsford; M W Whitehouse
Journal:  Agents Actions       Date:  1980-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.